Glossary of Terms

AIDS:

acquired immunodeficiency syndrome

ART:

antiretroviral therapy

ARTG:

Australian Register of Therapeutic Drugs

ASHM:

Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine

BMD:

bone mineral density

eCrCl:

estimated creatinine clearance rate

eGFR:

estimated glomerular filtration rate

GAHT

gender-affirming hormone therapy

FTC:

emtricitabine (trade name Emtriva)

HBV:

hepatitis B virus

HCV:

hepatitis C virus

HIV:

human immunodeficiency virus

iPrEx:

Pre-exposure Prophylaxis Initiative

MSM:

men who have sex with men

nPEP:

non-occupational post-exposure prophylaxis

NSP:

needle and syringe program

OST:

Opioid Substitution Therapy

PBAC:

Pharmaceutical Benefits Advisory Committee

PBS:

Pharmaceutical Benefits Scheme

PCR:

urine protein: creatinine clearance

PEP:

post-exposure prophylaxis

PIS:

Personal Importation Scheme

PoCT:

point-of-care test

PrEP:

pre-exposure prophylaxis

PWID:

people who inject drugs

s100

a section of the Pharmaceutical benefits Scheme which provides access to highly specialised drugs

STI:

sexually transmissible infection

TD*:

tenofovir disoproxil maleate or fumarate or phosphate

TDF:

tenofovir disoproxil fumarate (trade name Viread)

TDM:

tenofovir disoproxil maleate (trade name Trucitavir)

TDP:

tenofovir disoproxil phosphate (trade name Tenofovir EMT Lupin

TDF/FTC:

tenofovir disoproxil fumarate coformulated with emtricitabine (trade name Truvada, or in generic form Tenvir). In Australia, the TGA has also approved the generic Trucitavir, which is coformulated tenofovir disoproxil maleate and emtricitabine and Tenofovir EMT Lupin which is co-formulated tenofovir disoproxil phosphate and emtricitabine

TFV-DP:

tenofovir diphosphate

TGA:

Therapeutic Goods Administration

TGM:

Transgender Men

TGW:

Transgender Women

WHO:

World Health Organization